JLK, Inc (322510) Fair Value & Analysis
Industrials · KR · Market cap 131B KRW
Fair value as of: Jun 26, 2026
Analysis
JLK, Inc (322510) currently trades at 4,465 KRW, while our model-based Fair Value estimate is 661.16 KRW — implying the stock looks roughly 85.2% overvalued today. We read business quality at 95/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
About the company
JLK, Inc. provides diagnosis support to the patients with its AI-driven medical platform in South Korea. The company offers AI medical and AI security solutions. Its AI platform provides on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases. The company provides medical management, medical treatment, and medical service in brain diseases, such as ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer's disease; and in lung diseases, coronary artery disease, prostate cancer, and digital pathology. JLK, Inc. was formerly known as JLK INSPECTION Co.,Ltd. JLK, Inc. was incorporated in 2014 and is based in Cheongju-si, South Korea.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is JLK, Inc (322510) undervalued?
What is the fair value of 322510?
What is the quality score of 322510?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.